novo nordisk reuters - Search News

News

Novo Nordisk to sell Wegovy through telehealth firms

Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers

Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers, Ro and LifeMD to sell Wegovy, as it looks to stem sales of copies of its popular weight-loss drug and expand access to cash-paying patients.

Wall Street Journal · 9h

Hims & Hers to Sell Novo Nordisk’s Wegovy in U.S., Shares Soar

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity.

MarketWatch · 10h

Hims & Hers Rallies After Novo Nordisk Deal on Wegovy

Shares of online pharmacy Hims & Hers surged after it struck a deal with Danish obesity drug maker Novo Nordisk to sell its Wegovy drug in the U.S. In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions,

Reuters4d

Novo Nordisk A/S

according to a Reuters survey. April 14, 2025 Novo Nordisk warns consumers about counterfeit versions of Ozempic in US Danish drugmaker Novo Nordisk said on Monday several hundred ...

NJBIZ21h

Novo Nordisk scores court win against GLP-1 copycat compounders

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

FDA free to pursue semaglutide compounders after latest court ruling

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

5don MSN

Novo Nordisk's stellar Wegovy-fuelled run of hiking sales guidance could be ending

Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results